Upcoming Launch
Expanding Our Horizons
Parenteral (Sterile Injectables) Division
As part of our commitment to addressing critical healthcare needs and broadening our manufacturing footprint, Vitex Pharma is proud to announce the upcoming launch of our Parenteral Manufacturing Division.
The physical building structure and civil cleanroom infrastructure for this dedicated sterile section are 100% complete. Designed to meet the stringent regulatory requirements for small and large-volume parenterals, the facility features advanced aseptic processing bays, sterile air filtration systems, and terminal sterilization capabilities. Machinery installation and validation protocols are underway as we prepare for full regulatory licensing and commercial commissioning.